Association for Accessible Medicines (Formerly Generic Pharmaceutical Assoc.)
National trade organization representing the interests of generic drug manufacturers.
Based in DC
AI Overview
With $1.6M in lobbying spend across 34 quarterly filings, Association for Accessible Medicines (Formerly Generic Pharmaceutical Assoc.) is a significant lobbying presence. Their lobbying covers 7 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $200K |
| 2019 | $200K |
| 2020 | $190K |
| 2021 | $160K |
| 2022 | $240K |
| 2023 | $160K |
| 2024 | $200K |
| 2025 | $240K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Taxation, Medicare/Medicaid, Trade, Pharmacy and 2 more
- •- Issues relating to bioequivalence and related administrative procedures.
- •- Issues relating to prescription drug abuse.
- •- Issues relating to the labeling of generic drugs.
- •- FAST Generics Act / CR
- •Issues related to tax reform concerning Border Adjustment Tax
- •Provisions from the Bipartisan Budget Act of 2015 concerning the Medicaid rebate program.
- •Issues related to the Medicare low-income subsidy.
- •Issues related to the cost of prescription drugs.
- •Issues
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.